Zhejiang Wecome Pharmaceutical Company Limited’s Net Profit Rose 21.1% in First Quarter of 2023

Zhejiang Wecome Pharmaceutical Company Limited (浙江维康药业股份有限公司) (300878.SZ) reported a net profit of 28 million yuan in the first quarter of 2023, up 21.1% year-on-year.

Meanwhile, the company posted 195.7 million yuan in revenue, up 6.5% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 579.5 million yuan in total liabilities, with a liability-to-asset ratio of 28.7%.